These Healthcare stocks are trading higher:
-Neximmune Inc (NEXI) stock is trading at $21.94, an increase of $12.64, or 138.01%, on high volume. Neximmune Inc gets a Sentiment Score of Bullish from InvestorsObserver. Neximmune Inc next reports earnings on February 15.
-PepGen Inc (PEPG) stock is trading at $10.75, an increase of $3.5, or 46.9%, on high volume. Pepgen Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.80. Pepgen Inc next reports earnings on February 6.
-Vivos Therapeutics Inc (VVOS) stock is trading at $8.28, a gain of $1.67, or 23.49%, on high volume. Vivos Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver. Vivos Therapeutics Inc next reports earnings on February 12.
-Aclarion Inc (ACON) stock is trading at $2.92, a gain of $0.42, or 16.37%, on low volume. Aclarion Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $48.02. Aclarion Inc next reports earnings on February 13.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Nyxoah SA (NYXH) stock is trading at $7.93, a loss of $4.41, or 35.74%, on high volume. Nyxoah S A gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $11.40. Nyxoah S A next reports earnings on February 6.
-Revelation Biosciences Inc (REVB) stock is trading at $8.55, a decline of $4.44, or 34.18%, on high volume. Revelation Biosciences Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $343.84. Revelation Biosciences Inc next reports earnings on February 7.
-Aileron Therapeutics Inc (ALRN) stock is trading at $4.61, a loss of $1.33, or 22.55%, on low volume. Aileron Therapeutics Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.00.
-Avrobio Inc (AVRO) stock is trading at $1.14, a decline of $0.24, or 17.52%, on high volume. Avrobio Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $3.50. Avrobio Inc next reports earnings on February 7.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
